Cited by 715Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchDementia and Cognitive Impairment Research

Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease

Open access
Busche, Marc Aurel, Chen, Xiaowei, Henning, Horst A., Reichwald, Julia, Staufenbiel, Matthias, Sakmann, Bert, Konnerth, Arthur·2012·Proceedings of the National Academy of Sciences

Abstract

Alzheimer's disease (AD) is characterized by a progressive dysfunction of central neurons. Recent experimental evidence indicates that in the cortex, in addition to the silencing of a fraction of neurons, other neurons are hyperactive in amyloid-β (Aβ) plaque-enriched regions. However, it has remained unknown what comes first, neuronal silencing or hyperactivity, and what mechanisms might underlie the primary neuronal dysfunction. Here we examine the activity patterns of hippocampal CA1 neurons in a mouse model of AD in vivo using two-photon Ca(2+) imaging. We found that neuronal activity in the plaque-bearing CA1 region of older mice is profoundly altered. There was a marked increase in the fractions of both silent and hyperactive neurons, as previously also found in the cortex. Remarkably, in the hippocampus of young mice, we observed a selective increase in hyperactive neurons already before the formation of plaques, suggesting that soluble species of Aβ may underlie this impairment. Indeed, we found that acute treatment with the γ-secretase inhibitor LY-411575 reduces soluble Aβ levels and rescues the neuronal dysfunction. Furthermore, we demonstrate that direct application of soluble Aβ can induce neuronal hyperactivity in wild-type mice. Thus, our study identifies hippocampal hyperactivity as a very early functional impairment in AD transgenic mice and provides direct evidence that soluble Aβ is crucial for hippocampal hyperactivity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1206171109

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The early abnormal neuronal hyperactivity phenotype in AppNL-G-F mice has been shown to be dependent on soluble amyloid beta.

    “which has been shown to be dependent on soluble Aβ [38–40]”

    From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [39]

    The Discussion reports that soluble Aβ causally promotes early hippocampal hyperactivity: reducing soluble Aβ reversed hyperactivity, while applying it induced hyperactivity in wild-type mice. But the Results identify the study mice as APPswe/PS1 G384A transgenic mice, not AppNL-G-F mice, so this source does not establish the phenotype’s dependence on soluble Aβ in the specified model. Page numbers are not available in the supplied copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Effects of amyloid beta on neuronal activity and synaptic function often stem from soluble aggregates similar to those produced in much greater numbers by oligodendrocytes.

    “Rather than being plaque dependent, the effects of Aβ on neuronal activity and synaptic function often stem from soluble aggregates similar to those we see produced in much greater numbers by oligodendrocytes [32,39].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Busche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A.
Affiliations
  • Center for Integrated Protein Science Munich (DE)
  • Novartis Institutes for BioMedical Research (CH)
  • Technical University of Munich (DE)
Corresponding author
Konnerth, Arthur
Venue
Proceedings of the National Academy of Sciences
Published
2012-05-16
Volume
109
Issue
22
Pages
8740-8745
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2035466313
Cited by
715
References
48
Citations by year
2026: 56 · 2025: 72 · 2024: 78 · 2023: 71 · 2022: 66 · 2021: 76 · 2020: 57 · 2019: 41 · 2018: 38 · 2017: 35 · 2016: 38 · 2015: 27 · 2014: 31 · 2013: 20 · 2012: 7
FWCI
18.23
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Technische Universität München
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, soluble amyloid-beta, CA1 pyramidal neurons, neuronal hyperactivity, neuronal silencing, amyloid plaques, gamma-secretase inhibition, two-photon calcium imaging, transgenic mouse model
MeSH terms
Age Factors, Alanine, Alzheimer Disease, Animals, Azepines, Calcium, Disease Models, Animal, Hippocampus, Humans, Mice, Transgenic, Neurons, Amyloid beta-Peptides, Microscopy, Fluorescence, Multiphoton, Mice, Amyloid Precursor Protein Secretases, CA1 Region, Hippocampal, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review